# Effect of a Combination of Treatment of Reginmune Capsule and Immunofree Tablets in the Treatment of Mild to Moderate COVID-19 Patients

> **NCT04494204** · PHASE2,PHASE3 · COMPLETED · sponsor: **PUNEET MITTAL** · enrollment: 100 (actual)

## Conditions studied

- Treatment of Covid-19 Virus Infection

## Interventions

- **COMBINATION_PRODUCT:** Immunofree tablets and Reginmune capsule

## Key facts

- **NCT ID:** NCT04494204
- **Lead sponsor:** PUNEET MITTAL
- **Sponsor class:** NETWORK
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-07
- **Primary completion:** 2020-12-01
- **Final completion:** 2020-12-20
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04494204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04494204, "Effect of a Combination of Treatment of Reginmune Capsule and Immunofree Tablets in the Treatment of Mild to Moderate COVID-19 Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04494204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*